UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

Digestive diseases and sciences, 2019-07, Vol.64 (7), p.1945-1951

2019

Volltextzugriff (PDF)

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

The Journal of clinical investigation, 2013-09, Vol.123 (9), p.3983-3996

2013

Volltextzugriff (PDF)

Association of Celiac Serology Normalization With the Risk of Hypothyroidism: A Cohort Study

The American journal of gastroenterology, 2022-09, Vol.117 (9), p.1428-1436

2022

Volltextzugriff (PDF)

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

Therapeutic advances in gastroenterology, 2021, Vol.14, p.17562848211053112-17562848211053112

2021

Volltextzugriff (PDF)

The use of tofacitinib in the treatment of inflammatory bowel disease

Immunotherapy, 2018-08, Vol.10 (10), p.837-849

2018

Volltextzugriff (PDF)

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

Journal of Crohn's and colitis, 2022-12, Vol.16 (12), p.1882-1892

2022

Volltextzugriff (PDF)

New Diagnosis of Acquired Immunodeficiency Syndrome in a Patient With Crohn's Disease

ACG case reports journal, 2019-04, Vol.6 (4), p.e00056-e00056

2019

Volltextzugriff (PDF)

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases

Vaccines (Basel), 2022-07, Vol.10 (8), p.1186

2022

Volltextzugriff (PDF)

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (2), p.454-467

2022

Volltextzugriff (PDF)

Sa1740 - Tofacitinib for the Induction and Maintenance of Medically-Resistant Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-376-S-376

2018

Volltextzugriff (PDF)

Management of Patients With Inflammatory Bowel Disease, Pneumocystis jirovecii and Human Immunodeficiency Virus Infection: 1988

The American journal of gastroenterology, 2017-10, Vol.112, p.S1099

2017

Volltextzugriff (PDF)

Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency

Digestive diseases and sciences, 2015-07, Vol.60 (7), p.1941-1947

2015

Volltextzugriff (PDF)

The use of artificial intelligence to identify subjects with a positive FOBT predicted to be non-compliant with both colonoscopy and harbor cancer

Digestive and liver disease, 2023-09, Vol.55 (9), p.1253-1258

2023

Volltextzugriff (PDF)

Tu1497: COMPARISON OF THE RISK OF CLINICAL RECURRENCE AFTER ILEOCOLONIC RESECTION FOR CROHN'S DISEASE FOR MODIFIED RUTGEERTS’ SCORE I2A AND I2B CATEGORIES: INDIVIDUAL PATIENT DATA META-ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-987

2022

Volltextzugriff (PDF)

The risk of advanced neoplasia after polypectomy of one to two non-advanced adenomas less than 5 mm in size vs. normal colonoscopy

Digestive and liver disease, 2022-09, Vol.54 (9), p.1250-1256

2022

Volltextzugriff (PDF)

Simplified Daily Assessments of Sleep Quality, Pain and Quality of Life in IBD Patients Correlate with Validated Measures: P-062

The American journal of gastroenterology, 2018-02, Vol.113, p.S15

2018

Volltextzugriff (PDF)

Sa1773 POST-OPERATIVE PROPHYLAXIS WITH ANTI-TNF IN PATIENTS WITH CROHN'S DISEASE WHO ARE ANTI-TNF EXPERIENCED IS ASSOCIATED WITH HIGHER RATES OF PROPHYLAXIS FAILURE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-417-S-417

2020

Volltextzugriff (PDF)

The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants

Cancer, 2024-01, Vol.130 (2), p.256-266

2024

Volltextzugriff (PDF)

P051 IBD PATIENT COMPLIANCE WITH MOBILE AND WEARABLE TECHNOLOGIES AS TOOLS TO ASSESS QUALITY OF LIFE, SLEEP QUALITY AND PAIN

Gastroenterology (New York, N.Y. 1943), 2018-01, Vol.154 (1), p.S26-S27

2018

Volltextzugriff (PDF)

Do Nurses and Physicians Know How Much Pain and Anxiety Their IBD Inpatients Have?: P-040

The American journal of gastroenterology, 2018-02, Vol.113, p.S10

2018

Volltextzugriff (PDF)

Endoscopic Postoperative Recurrence In Crohn's Disease After Curative Ileocecal Resection With Early Prophylaxis By Anti-Tnf, Vedolizumab Or Ustekinumab: A Real-World Multicenter European Study

Journal of Crohn's and colitis, 2022, Vol.16 (12), p.1882

2022

Volltextzugriff (PDF)

P051 IBD PATIENT COMPLIANCE WITH MOBILE AND WEARABLE TECHNOLOGIES AS TOOLS TO ASSESS QUALITY OF LIFE, SLEEP QUALITY AND PAIN

Inflammatory bowel diseases, 2018-01, Vol.24 (suppl_1), p.S18-S19

2018

Volltextzugriff (PDF)

Mo1830 - Sleep Fragmentation Measured by Wearable Device is an Indicator of Clinical Disease Activity in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-817-S-818

2018

Volltextzugriff (PDF)

Increased Risk of Endoscopic Disease Progression With Rutgeertsʼ i2a and i2b Recurrence: Implications for Disease Prevention: 694

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S389-S390

2018

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(41)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

Association of Celiac Serology Normalization With the Risk of Hypothyroidism: A Cohort Study

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

The use of tofacitinib in the treatment of inflammatory bowel disease

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

New Diagnosis of Acquired Immunodeficiency Syndrome in a Patient With Crohn's Disease

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

Sa1740 - Tofacitinib for the Induction and Maintenance of Medically-Resistant Ulcerative Colitis

Management of Patients With Inflammatory Bowel Disease, Pneumocystis jirovecii and Human Immunodeficiency Virus Infection: 1988

Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency

The use of artificial intelligence to identify subjects with a positive FOBT predicted to be non-compliant with both colonoscopy and harbor cancer

Tu1497: COMPARISON OF THE RISK OF CLINICAL RECURRENCE AFTER ILEOCOLONIC RESECTION FOR CROHN'S DISEASE FOR MODIFIED RUTGEERTS’ SCORE I2A AND I2B CATEGORIES: INDIVIDUAL PATIENT DATA META-ANALYSIS

The risk of advanced neoplasia after polypectomy of one to two non-advanced adenomas less than 5 mm in size vs. normal colonoscopy

Simplified Daily Assessments of Sleep Quality, Pain and Quality of Life in IBD Patients Correlate with Validated Measures: P-062

Sa1773 POST-OPERATIVE PROPHYLAXIS WITH ANTI-TNF IN PATIENTS WITH CROHN'S DISEASE WHO ARE ANTI-TNF EXPERIENCED IS ASSOCIATED WITH HIGHER RATES OF PROPHYLAXIS FAILURE

The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants

P051 IBD PATIENT COMPLIANCE WITH MOBILE AND WEARABLE TECHNOLOGIES AS TOOLS TO ASSESS QUALITY OF LIFE, SLEEP QUALITY AND PAIN

Do Nurses and Physicians Know How Much Pain and Anxiety Their IBD Inpatients Have?: P-040

Su1488: WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFα HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES

Endoscopic Postoperative Recurrence In Crohn's Disease After Curative Ileocecal Resection With Early Prophylaxis By Anti-Tnf, Vedolizumab Or Ustekinumab: A Real-World Multicenter European Study

P051 IBD PATIENT COMPLIANCE WITH MOBILE AND WEARABLE TECHNOLOGIES AS TOOLS TO ASSESS QUALITY OF LIFE, SLEEP QUALITY AND PAIN

Mo1830 - Sleep Fragmentation Measured by Wearable Device is an Indicator of Clinical Disease Activity in Inflammatory Bowel Disease

Increased Risk of Endoscopic Disease Progression With Rutgeertsʼ i2a and i2b Recurrence: Implications for Disease Prevention: 694

Suchergebnisse filtern